Dark

ARMP
Armata Pharmaceuticals, Inc. Common Stock
stock NYSEAMERICAN

At Close

Jul 17, 2026 3:59:55 PM EDT

4.49USD+19.282%(+0.73)271,344

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 16, 2026 8:16:30 AM EDT

4.15USD+10.372%(+0.39)0

After-hours

Jul 17, 2026 4:40:30 PM EDT

4.22USD-5.909%(-0.27)10,495

OverviewOptionsHistoricalExchangesShortsNews

Jan 5, 2022

08:37AM EST Armata Pharmaceuticals Provides Update On Pseudomonas Respiratory Programs Benzinga

08:04AM EST Armata Pharma Updates On Pseudomonas Respiratory Programs RTTNews

08:03AM EST Armata Pharmaceuticals Provides Update on Pseudomonas Respiratory Programs PR Newswire

Nov 18, 2021

08:10AM EST Armata Announces FDA Clearance Of IND To Initiate Phase 1b/2a Trial Of AP-SA02 In Staphylococcus Aureus Bacteremia RTTNews

08:04AM EST Armata Pharmaceuticals Says Investigational Drug Application For AP-SA02 Has Been Cleared By FDA; Co Proceeding With Phase 1b/2a Clinical Study Benzinga

08:02AM EST Armata Pharmaceuticals Provides Regulatory and Clinical Update Reflecting PR Newswire

Nov 10, 2021

06:08PM EST Armata Pharmaceuticals Q3 EPS $(0.22) Up From $(0.31) YoY, Sales $1.25M Up From $288.00K YoY Benzinga

04:06PM EST Armata Pharmaceuticals Announces Third Quarter Results and Provides General PR Newswire

Nov 4, 2021

08:00AM EDT Armata Pharmaceuticals to Present at the 2021 World Antimicrobial Resistance PR Newswire

Nov 2, 2021

08:03AM EDT Armata Enters Lease to Build State-of-the-Art R&D and GMP Manufacturing Facility PR Newswire

Oct 28, 2021

06:42PM EDT Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals PR Newswire

Sep 8, 2021

08:02AM EDT Armata Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global PR Newswire

Aug 12, 2021

04:52PM EDT Armata Pharmaceuticals Q2 EPS $(0.25) Up From $(0.26) YoY Benzinga

04:06PM EDT Armata Pharmaceuticals Announces Second Quarter Results and Provides General PR Newswire

Aug 2, 2021

08:06AM EDT Biotechnology company Armata Pharmaceuticals, Inc. (ARMP) announced Monday that its current Chief Executive Officer, Todd Patrick, is retiring from day-to-day active management of the company, effective today. RTTNews

07:41AM EDT Armata Pharma CEO Todd Patrick To Retire, Effective Monday; Appoints Brian Varnum As CEO RTTNews

07:39AM EDT Armata Pharmaceuticals CEO Todd R. Patrick To Retire From Day-To-Day Active Management; Brian Varnum Appointed CEO Benzinga

07:31AM EDT Armata Pharmaceuticals Announces Chief Executive Officer Transition PR Newswire

Jul 7, 2021

07:31AM EDT Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare PR Newswire

May 13, 2021

04:05PM EDT Armata Pharmaceuticals Announces First Quarter Results and Provides General PR Newswire

Mar 22, 2021

08:30AM EDT 10 Biggest Price Target Changes For Monday Benzinga

06:29AM EDT HC Wainwright & Co. Maintains Buy on Armata Pharmaceuticals, Raises Price Target to $7 Benzinga

Mar 18, 2021

04:09PM EDT Armata Pharmaceuticals Q4 EPS $(0.36) Up From $(0.41) YoY, Sales $504.00K Benzinga

04:06PM EDT Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Results and PR Newswire

05:23AM EDT Armata Pharmaceuticals 10%+ Owner Innoviva Strategic Opportunities LLC Reported Purchase of 8,571,870 Shares @ Avg Price of $3.25/Share in Form 4 Filing on Wednesday Benzinga

Mar 17, 2021

04:01PM EDT Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $20 PR Newswire

Mar 16, 2021

11:02AM EDT Armata Pharmaceuticals to Present at the Oppenheimer 31st Annual Healthcare PR Newswire

Jan 30, 2021

11:10AM EST Notable Insider Buys Seen In The Past Week: Green Brick, Intel, Teledyne And More Benzinga

Jan 27, 2021

07:21AM EST Armata Enters Agreement To Sell Common Stock And Warrant Securities To Innoviva Strategic Opportunities LLC RTTNews

07:11AM EST Armata Pharmaceuticals Announces $20M Investment to Support Advancement of the Company's Bacteriophage Development Programs Benzinga

07:01AM EST Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement PR Newswire

Dec 9, 2020

07:31AM EST Armata Pharma Adds Robin Kramer To Board RTTNews

07:30AM EST Armata Pharmaceuticals Announces the Addition of Robin C. Kramer to its Board PR Newswire

Nov 12, 2020

04:15PM EST Armata Pharmaceuticals Q3 EPS $(0.31) Up From $(0.73) YoY Benzinga

04:05PM EST Armata Pharmaceuticals Announces Third Quarter 2020 Results and Provides PR Newswire

Oct 29, 2020

07:31AM EDT Armata Pharmaceuticals Issues Letter to Shareholders PR Newswire

Oct 26, 2020

07:36AM EDT Armata Pharma Appoints Mina Pastagia As VP Of Clinical Development RTTNews

07:31AM EDT Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of PR Newswire

Oct 15, 2020

07:38AM EDT Armata Pharma Announces Clearance Of IND Application To Initiate Phase 1b/2a Clinical Trial Of AP-PA02 RTTNews

07:31AM EDT Armata Pharmaceuticals Announces Clearance Of Investigational New Drug Application To Initiate Phase 1b/2a Clinical Trial Of Lead Candidate AP-PA02 In Pseudomonas Aeruginosa Infections Benzinga

07:31AM EDT Application to Initiate Phase 1b/2a Clinical Trial of Lead Candidate AP-PA02 in Pseudomonas aeruginosa Infections PR Newswire

Sep 29, 2020

07:30AM EDT Armata Pharmaceuticals to Present at the Virtual 2020 World Antimicrobial PR Newswire

Sep 11, 2020

07:31AM EDT Armata Pharmaceuticals Announces Participation in Upcoming Investor Conferences PR Newswire

Aug 13, 2020

04:19PM EDT Armata Pharmaceuticals Q2 EPS $(0.26) Up From $(0.69) YoY, Sales $31.00K Benzinga

04:06PM EDT Armata Pharmaceuticals Announces Second Quarter 2020 Results and Provides PR Newswire

.dark-mode .YyLCTV{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .YyLCTV{ color: #333333; background-color: white; border: 2px solid #333333; }ARMPArmata Pharmaceuticals, Inc. Common Stockstock NYSEAMERICAN

ARMP
Armata Pharmaceuticals, Inc. Common Stock
stock NYSEAMERICAN